A Worldwide, Open Label, Clinical Trial to Examine the Long Term Safety and Tolerability of Rizatriptan in Pediatric Migraineurs for the Treatment of Migraine With or Without Aura
Read time: 1 mins
Last updated:1st Feb 2010
To evaluate the safety and tolerability of rizatriptan in the long term treatment of acute migraine in pediatric patients age 12-17 years.
|Study start date||2010-02-01|